Benzos Acute cognitive effect from a single low-dose EPA/DHA capsule — plausible PK or rapid PD mechanism?

[fullofdetermination]

I'm trying to understand a reproducible acute effect from a standard fish-oil capsule and whether there is any pharmacokinetic or pharmacodynamic mechanism that could realistically fit the timing.

Context​

• Diazepam: 10 mg/day, long-term use, with established tolerance.
• Fluvoxamine: 300 mg/day.
• My measured nordiazepam concentration was ~1333 ng/mL, above the usual therapeutic reference range.
• The benzodiazepine taper has not started yet.
• I also have dysautonomia with marked cognitive and sensory intolerance, so I'm not assuming the effect is necessarily GABAergic; autonomic, vascular, or other mechanisms would also be relevant.

The fluvoxamine/diazepam interaction is important here. In a human pharmacokinetic study using 100–150 mg/day fluvoxamine, diazepam apparent oral clearance was reduced by approximately 65%, while mean diazepam half-life increased from about 51 to 118 hours. Elimination of its active metabolite N-desmethyldiazepam (nordiazepam) was also markedly inhibited.

I'm on 300 mg/day fluvoxamine, but I don't know of quantitative human PK data establishing exactly how much additional inhibition occurs at that dose, so I'm not assuming a specific half-life for my own case.

Study:https://pubmed.ncbi.nlm.nih.gov/7955810/


I occasionally take a single standard fish-oil capsule containing 180 mg EPA + 120 mg DHA (roughly 1 g total fish oil), usually around 7 hours after my diazepam dose.

Repeatedly, within roughly 3 hours, I experience a marked improvement in cognitive/sensory tolerance, most noticeably an increased ability to read for substantially longer.

It does not feel sedating. If anything, subjectively it feels like improved cognitive endurance.

I realize this is an N=1 observation and does not establish causality. Expectancy, coincidence, day-to-day variability, or another uncontrolled variable remain possible. I'm interested specifically in whether there is a biologically and quantitatively plausible mechanism that could fit the timing.

Relevant literature / what led me to ask​

I found several experimental papers showing that DHA/PUFAs can affect neuronal membrane proteins or GABA-A function:

Søgaard et al. (2006) — GABA(A) receptor function is regulated by lipid bilayer elasticity

https://pubmed.ncbi.nlm.nih.gov/17059229/

Nabekura et al. (1998) — Functional modulation of human recombinant GABA-A receptor by docosahexaenoic acid

https://pubmed.ncbi.nlm.nih.gov/9556589/

Poling et al. (1996) — Docosahexaenoic acid block of neuronal voltage-gated K+ channels

https://pubmed.ncbi.nlm.nih.gov/8938727/

Stillwell & Wassall (2003) — Docosahexaenoic acid: membrane properties of a unique fatty acid

https://pubmed.ncbi.nlm.nih.gov/14580707/

I'm not taking these studies as evidence that an ordinary oral DHA dose can reproduce these effects acutely in humans.

In fact, that's one of the main things I'm trying to understand: whether oral exposure from only 120 mg DHA + 180 mg EPA could produce concentrations anywhere relevant to these experimental mechanisms within a few hours.

1. Could this plausibly be pharmacokinetic?​

Given the prolonged disposition of diazepam/nordiazepam in this setting and my relatively high nordiazepam concentration, I find it difficult to see how one ordinary fish-oil capsule could substantially change total benzodiazepine concentrations within ~3 hours.

However, I don't want to assume that PK is irrelevant.

Could EPA/DHA acutely affect any of the following enough to alter effective diazepam/nordiazepam exposure?

• CYP-mediated metabolism;
• plasma protein binding / free drug fraction;
• tissue distribution;
• intestinal absorption;
• transporters;
• or another PK process.

More importantly, is there any reason to think the magnitude of such an interaction from only 180 mg EPA + 120 mg DHA could be pharmacologically meaningful?

A quantitative argument here would be particularly useful.

2. Could there instead be a rapid pharmacodynamic effect?​

If a meaningful PK interaction is implausible, are there pharmacodynamic mechanisms that could operate within hours, without requiring weeks of incorporation of DHA into neuronal membrane phospholipids?


Possibilities I'm wondering about include:

• direct effects of circulating/unesterified fatty acids on ion channels or membrane proteins;
• acute GABA-A modulation;
• glutamatergic signaling;
• changes in membrane biophysics;
• neurosteroid signaling;
• rapidly generated lipid mediators;
• inflammatory signaling;
• autonomic or cerebrovascular effects.

The experimental literature shows that DHA can modulate some of these systems when directly available at sufficient concentrations.

What I cannot establish is whether an ordinary oral dose could generate relevant unesterified EPA/DHA concentrations in plasma or CNS tissue within ~3 hours.


That seems to be the critical missing bridge:

oral dose → absorption → circulating unesterified EPA/DHA → CNS exposure → local concentration at membrane/channel/receptor → functional effect

Is any part of that chain quantitatively plausible after such a small oral dose?

3. Does chronic benzodiazepine exposure/tolerance materially change the question?​

Could chronic benzodiazepine exposure, tolerance, and receptor adaptation make the functional effect of an otherwise small perturbation in membrane or ion-channel function more noticeable?

I'm not claiming that a plasma nordiazepam level of 1333 ng/mL establishes saturated GABA-A occupancy or any particular receptor state.

I'm mentioning the concentration mainly because, together with the markedly impaired elimination expected from the fluvoxamine interaction, it makes a large and rapid fluctuation in total benzodiazepine exposure seem unintuitive.

4. Could dysautonomia provide a non-GABAergic explanation?​

Given the dysautonomia, is there any plausible acute effect of EPA/DHA or downstream lipid mediators on:

• autonomic tone;
• cerebral blood flow;
• endothelial signaling;
• vascular function;
• or related physiology

that could improve cognitive/sensory tolerance within a few hours?

I'm mainly looking for mechanistic reasoning, quantitative PK arguments, or relevant literature, rather than treatment recommendations.

 

[Keif' Richards]

Please stop me if I am misunderstanding this. I am well-versed in the nature of Fluvoxamine (Luvox) and its effects relative to Cytochrome P450 activity. SSRI's are known for this effect in general, however, Fluvoxamine is in a league of its own in regard to the severity of this effect. A careful practitioner who knows their shit would be incredibly cautious when prescribing Fluvoxamine to any individual, knowing that its effects on drug metabolism can be so severe as to cause LETHAL reactions.

The Occam's Razor here is that you are on a high dosage of Fluvoxamine. Doses start at 50mg and 100mg would be considered the bread and butter of modern prescribing practices. The effect upon the regulation of CYP450 enzymes increases in a linear fashion as the dosage of Fluvoxamine is increased. In my own experience and based upon research I've skimmed, the serious effects of the combination tend to become most pronounced as the drug starts reaching steady-state levels around day ~5. There are multiple accounts of patients on Opioids, namely Methadone (highly affected by P450 kinetics) and/or Benzodiazepines who arrive in states of stupor, hypoxia etc. requiring Opioid agonists and in one case, intubation.

See, these patients also had shitty doctors who didn't bother to crack open Wikipedia prior to writing the scripts. Fluvoxamine, for those who know, is essentially the archetype for this sort of scenario. It is at a crossroads of being a heavy modulator, while also being commonly available unlike say, Ketoconazole (the mack daddy). This is not eldritch information. We have more information available at our fingertips more than ever before, yet somehow, doctors just get stupider and stupider.

Occam's Razor: your Fluvoxamine triggered a metabolic back-log for your medication and that is what you are experiencing. Furthermore, yes, some do report that these supplements that you have listed indeed to possess acute, subjective effects on cognition to a mild degree so that is not really out of the ordinary either.

You can either tell your doctor what's up or continue grooving on what is essentially a 3x higher-than-actually-prescribed dose of Diazepam. Eventually, he or she might end up killing you accidentally though so it is a double-edged sword if I've ever seen one.

 

[fullofdetermination]

Hey, thank you for your post.

I am aware about Luvox inhibiting everything strongly and unfortunately I learned this in the worst way. Most psychiatrists don't know shit about interactions and PK and I had to learn for myself. I was on diazepam already when one doctor decided to swap me from sertraline to fluvoxamine and then I got a second opinion from a big shot that saw nothing wrong and prescribed me. A third one, an integrative, would do exactly the same, what a joke.

When I learnt about that I was already years on fluvoxamine 100mg. The worst part is that my parents didn't believe when I developed dysautonomia and central sensibilization mimicking CFS and then when I was bedbound they put me as inpatient in a place with a psychiatrist that updosed to 300mg even with my objections.

Now, knowing that is the main motivation that I want to know if omega 3 is safe for me because it really helps. Sometimes if something is too good to be true it's because it is, so I got skeptical if omega 3 isn't being a PK problem on CYP3A4 added to Luvox or a PD problem that would anyway increase my tolerance or dessensitize the gaba receptors.

It doesn't seem an option to quit Luvox now that I got on it: my system got used with the new PK and with the uber levels of benzos in my blood. Due to it I think I will need to do a glacial taper of diazepam that can take a decade. But if omega 3 is safe, at least it seems I can have a life and I am treating maybe inflammation or maybe hypoperfusion in the brain with it.